Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | Lapatinib | 0.01 | uM | 8 | 156.25 | 23.19 | 590.00 | 390.75 | 1.5099 | 1.2128 |
| MCF 10A | 17-AAG | 0.031623 | uM | 8 | 156.25 | 23.19 | 45.00 | 390.75 | 0.1152 | 0.1767 |
| MCF 10A | Lapatinib | 0.1 | uM | 8 | 156.25 | 23.19 | 923.00 | 390.75 | 2.3621 | 1.4697 |
| MCF 10A | Erlotinib | 0.31623 | uM | 8 | 156.25 | 23.19 | 984.00 | 390.75 | 2.5182 | 1.5088 |
| MCF 10A | Linsitinib | 0.31623 | uM | 8 | 156.25 | 23.19 | 828.00 | 390.75 | 2.1190 | 1.4047 |
| MCF 10A | Lapatinib | 0.0016596 | uM | 8 | 156.25 | 23.19 | 685.00 | 390.75 | 1.7530 | 1.2954 |
| MCF 10A | 17-AAG | 0.01 | uM | 8 | 156.25 | 23.19 | 124.00 | 390.75 | 0.3173 | 0.5090 |
| MCF 10A | Lapatinib | 0.031623 | uM | 8 | 156.25 | 23.19 | 851.00 | 390.75 | 2.1779 | 1.4209 |
| MCF 10A | Lapatinib | 0.0033113 | uM | 8 | 156.25 | 23.19 | 510.00 | 390.75 | 1.3052 | 1.1351 |
| MCF 10A | 17-AAG | 0.1 | uM | 8 | 156.25 | 23.19 | 61.00 | 390.75 | 0.1561 | 0.2679 |
| MCF 10A | Linsitinib | 0.0033113 | uM | 8 | 156.25 | 23.19 | 401.00 | 390.75 | 1.0262 | 1.0127 |
| MCF 10A | Linsitinib | 3.1623 | uM | 8 | 156.25 | 23.19 | 82.00 | 390.75 | 0.2099 | 0.3634 |
| MCF 10A | Erlotinib | 0.0033113 | uM | 8 | 156.25 | 23.19 | 349.00 | 390.75 | 0.8932 | 0.9453 |
| MCF 10A | Lapatinib | 1 | uM | 8 | 156.25 | 23.19 | 200.00 | 390.75 | 0.5118 | 0.6969 |
| MCF 10A | 0 | uM | 8 | 156.25 | 23.19 | 318.00 | 390.75 | 0.8138 | 0.9014 | |
| MCF 10A | 0 | uM | 8 | 156.25 | 23.19 | 264.00 | 390.75 | 0.6756 | 0.8165 | |
| MCF 10A | 0 | uM | 8 | 312.50 | 114.17 | 735.00 | 1487.00 | 0.4943 | 0.6535 | |
| MCF 10A | 0 | uM | 8 | 312.50 | 114.17 | 1295.00 | 1487.00 | 0.8709 | 0.9267 | |
| MCF 10A | Linsitinib | 0.1 | uM | 8 | 312.50 | 114.17 | 1145.00 | 1487.00 | 0.7700 | 0.8637 |
| MCF 10A | Lapatinib | 3.1623 | uM | 8 | 312.50 | 114.17 | 488.00 | 1487.00 | 0.3282 | 0.4803 |
| MCF 10A | Linsitinib | 10 | uM | 8 | 312.50 | 114.17 | 270.00 | 1487.00 | 0.1816 | 0.2617 |
| MCF 10A | Erlotinib | 0.1 | uM | 8 | 312.50 | 114.17 | 1415.00 | 1487.00 | 0.9516 | 0.9734 |
| MCF 10A | Erlotinib | 19.9526 | uM | 8 | 312.50 | 114.17 | 162.00 | 1487.00 | 0.1089 | 0.0991 |
| MCF 10A | Erlotinib | 1 | uM | 8 | 312.50 | 114.17 | 278.00 | 1487.00 | 0.1870 | 0.2717 |
| MCF 10A | 17-AAG | 0.0031623 | uM | 8 | 312.50 | 114.17 | 736.00 | 1487.00 | 0.4950 | 0.6541 |